FDA Proposes Removal of Decongestants in Cold and Allergy Medications
In a significant move, the FDA has proposed the removal of decongestants from many over-the-counter (OTC) cold and allergy medications. This decision addresses concerns about their effectiveness. The FDA found insufficient evidence to support their ability to provide relief. Why is the FDA Proposing This Change? The FDA’s proposed action follows a comprehensive review of […]
U.S. Medication Makers Are Shifting Away from Chinese Suppliers – Here’s What That Means for Repackagers
In recent years, U.S. medication makers have begun reducing their reliance on Chinese suppliers for key medication components. This shift affects every part of the pharmaceutical ecosystem, representing a significant change in how medications are sourced and produced. Why Are Pharmaceutical Companies Rethinking Their Supply Chains? China has long been a leading supplier of Active […]